Skip to Content
77 Mass Ave

Night Shift Nightmare

Disrupting circadian rhythm increases cancer risk.
October 18, 2016

A handful of large studies of cancer risk factors have found that working the night shift, as nearly 15 percent of Americans do, boosts the chances of developing cancer.

MIT biologists have now found a link that may explain this heightened risk: in a study of mice, they found that two of the genes that control cells’ circadian rhythms also function as tumor suppressors. Disrupting these genes allows tumors to become more aggressive.

The researchers exposed mice to two different schedules. One group lived with a normal routine of 12 hours of light followed by 12 hours of darkness, while the other mice went onto a “jet lag” schedule: every two to three days, they were exposed to an additional eight hours of light. This mimics the biological-clock disruption that occurs when humans work night shifts or travel through multiple time zones. When this happens, the two genes that control the circadian clock, Bmal1 and Per2, don’t get the light cues that cause levels of the proteins they encode to oscillate throughout the day.

“Cells need the light cue, which is like a reset button for the clock,” says Thales Papagiannakopoulos, a former postdoc at MIT’s Koch Institute for Integrative Cancer Research, who worked with Koch Institute director Tyler Jacks on this study.

Under the jet lag scenario, tumors grew faster and were more aggressive than those in the mice living with a normal light/dark schedule. When the researchers kept the mice on a normal schedule but knocked out Bmal1 or Per2, tumors also grew faster. “If you disrupt these genes in every cell of the body, the light cues that you normally receive do not apply,” says Papagiannakopoulos. “It’s a way of taking a molecular hammer and just breaking this clock.”

Keep Reading

Most Popular

Rendering of Waterfront Toronto project
Rendering of Waterfront Toronto project

Toronto wants to kill the smart city forever

The city wants to get right what Sidewalk Labs got so wrong.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.